CD4 and breast carcinoma: Gu-Trantien et al. (Gu-Trantien et al. 2013) observed that CD4+T cells in the organism are an important immune-acting component in breast cancer, and that the stronger the immune response they generate, the better the disease-free survival (DFS) may be obtained.